|
|
| | CL 19506 7-5526 Basic information |
| | CL 19506 7-5526 Chemical Properties |
| Melting point | 350 °C | | density | 1.454±0.06 g/cm3(Predicted) | | solubility | DMSO (Sparingly, Sonicated), Methanol (Slightly) | | form | Solid | | pka | 9.62±0.50(Predicted) | | color | White to Off-White |
| Toxicity | mouse,LD50,intraperitoneal,1022mg/kg (1022mg/kg),National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, |
| | CL 19506 7-5526 Usage And Synthesis |
| Uses | N-1,3,4-Thiadiazol-2-ylacetamide is an impurity of Acetazolamide (A161500). Acetazolamide impurity B. | | Uses | N-1,3,4-Thiadiazol-2-ylacetamide is an impurity of Acetazolamide (A161500). Acetazolamide EP Impurity B |
| | CL 19506 7-5526 Preparation Products And Raw materials |
|